Pfizer to exit GSK's consumer health arm after spin-off
reuters.com
business
2022-06-01 07:52:14

A person walks past a Pfizer logo amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., April 1, 2021. REUTERS/Carlo Allegri/File PhotoRegister now for FREE unlimited access to Reuters.comLONDON, June 1 (Reuters) - Pfizer (PFE.N) plans to exit its 32% stake in Haleon, its consumer health joint venture with GSK (GSK.L), after the business is spun off as an independent company in July, GSK said on Wednesday.Pfizer has a 32% stake in Haleon, which produces Sensodyne toothpaste and Advil painkillers.
